Latest ABT reports update at 2024-02-16: 202320222021
Abbott Laboratories logo

Abbott Laboratories ABT

$ 113.66 0.16%

Country

usaUSA

IPO year

-

Industry

Medical devices

Stock Exchange

NYSESPB

CEO

Mr. Robert Ford

Employees in the company

107 000

Shares

1.74 B

Market Cap[1]

$ 198 B

EBITDA (LTM)

$ 8.28 B

P/E (LTM)

29.88

P/S (LTM)

4.14

EPS (LTM)

3.18

Abbott Laboratories is a global healthcare company founded in 1888. The company develops and manufactures a wide range of medical devices, diagnostics, and nutritional products. Abbott's products and services are used by healthcare professionals and patients in over 160 countries.

Abbott is known for its innovative solutions for healthcare challenges. The company invests heavily in research and development to develop new products and technologies that improve patient outcomes and reduce healthcare costs. Abbott's areas of focus include cardiovascular, diabetes care, diagnostic imaging, infectious diseases, nutrition, and pharmaceuticals.

Abbott is committed to social responsibility and sustainability. The company aims to reduce its environmental impact and promote the use of renewable energy. Abbott also supports community health initiatives and disaster relief efforts around the world.

Overall, it's a significant player in the healthcare industry, with a strong commitment to innovation, quality, and sustainability. The company's products and services have a significant impact on patient outcomes and the global healthcare system.

Other stocks of industry "Medical devices"

Issuer Price % 24h Market Cap Exchange Country
Dynatronics Corporation Dynatronics Corporation
DYNT
$ 0.45 - $ 1.74 M Nasdaq Capital Market usaUSA
Natus Medical Incorporated Natus Medical Incorporated
NTUS
$ 31.08 1.94 % $ 1.05 B Nasdaq Global Select Market,SPB usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
$ 4.1 -0.97 % $ 54.4 M Nasdaq Capital Market usaUSA
GBS GBS
GBS
$ 0.47 -0.57 % $ 7.12 M Nasdaq Global Market usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
$ 9.22 24.59 % $ 44.8 M Nasdaq Global Select Market chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
$ 3.05 -5.86 % $ 30.6 M Nasdaq Capital Market usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
$ 20.0 0.15 % $ 844 M Nasdaq Global Select Market,SPB usaUSA
Neovasc Neovasc
NVCN
$ 30.03 - $ 111 M Nasdaq Capital Market canadaCanada
Apollo Endosurgery Apollo Endosurgery
APEN
$ 10.0 - $ 475 M Nasdaq Global Market usaUSA
Silk Road Medical, Inc Silk Road Medical, Inc
SILK
$ 18.32 -2.08 % $ 711 M Nasdaq Global Select Market,SPB usaUSA
Sintx Technologies Sintx Technologies
SINT
$ 0.05 -1.98 % $ 187 K Nasdaq Capital Market usaUSA
Titan Medical Titan Medical
TMDI
$ 0.14 -26.32 % $ 19.6 M Nasdaq Global Select Market canadaCanada
BIOLASE BIOLASE
BIOL
$ 0.19 -0.68 % $ 243 K Nasdaq Capital Market usaUSA
Sensus Healthcare Sensus Healthcare
SRTS
$ 3.8 -3.06 % $ 61.8 M Nasdaq Capital Market usaUSA
ShockWave Medical ShockWave Medical
SWAV
$ 325.63 0.94 % $ 12 B Nasdaq Global Select Market,SPB usaUSA
Stryker Corporation Stryker Corporation
SYK
$ 357.87 -0.23 % $ 136 B NYSE,SPB usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 16.25 2.46 % $ 373 M Nasdaq Global Select Market,SPB usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 1.36 -3.55 % $ 47.1 M Nasdaq Global Select Market usaUSA
TransMedics Group TransMedics Group
TMDX
$ 73.94 -0.24 % $ 2.4 B Nasdaq Global Market usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
$ 35.41 0.31 % $ 2.31 B Nasdaq Global Market,SPB usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.